American Healthcare Has Normalized The Abnormal

A recent discussion on LinkedIn explored a variety of abnormal things in US healthcare that have now been normalized.

Cigna’s Evernorth Makes $100 Million AI Specialty Pharmacy Investment

Cigna’s Evernorth health is investing $100 million to support a new AI-powered program designed to improve how patients access and experience specialty pharmacy.

Why Axsome Stock Has Doubled In Nine Months

In this week’s edition of InnovationRx, we look at Axsome’s growing pipeline, HistoSonics innovative cancer treatment, state litigation over Medicaid work requirements, and more.

Trump Administration Boosts High-Deductible Healthcare Plans

One could argue if the rule changes being implemented by the Trump administration represent a further hollowing out of ACA in lieu of a Congressional repeal of the law.

States Sue Over Medicaid’s “Sick Enough” Test

States sue over whether Medicaid work requirement exemptions could force medically frail enrollees to prove they are “sick enough” to keep coverage.

GLP-1 Access Program May Enable Affordable Access For Some On Medicare

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But questions remain regarding the pilot and its cost.

Autonomous Pharmacies Are Becoming the Next Big Thing

The concept of automated pharmacy kiosks is slowly becoming more prevalent.

Anthropic’s New AI Workbench Mapped My Field For $26. Now Imagine It Aimed At The Rest Of Science

Anthropic’s Claude Science is a capable AI research workbench built for molecular biology. The opportunities for the rest of science are enormous.

A Drug-Resistant Fungus Is Spreading Through American Hospitals

Candida auris cases more than doubled from 2022 to 2024, CDC reports. How much of the rise in this drug-resistant fungus is real spread, and how much better detection?

Doctor Pay Is Up Because They’re Busy, Not Because Of Reimbursement

Physicians are working harder for more pay amid an ongoing doctor shortage while reimbursement rates are stagnant and expected to worsen, a new AMGA report shows.